175 related articles for article (PubMed ID: 11052322)
1. Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa.
Lichtenberger LM; Romero JJ; Gibson GW; Blank MA
Dig Dis Sci; 2000 Sep; 45(9):1792-801. PubMed ID: 11052322
[TBL] [Abstract][Full Text] [Related]
2. Nonclinical model for assessing gastric effects of bisphosphonates.
Blank MA; Ems BL; Gibson GW; Myers WR; Berman SK; Phipps RJ; Smith PN
Dig Dis Sci; 1997 Feb; 42(2):281-8. PubMed ID: 9052507
[TBL] [Abstract][Full Text] [Related]
3. Mucosal irritative and healing impairment action of risedronate in rat stomachs: comparison with alendronate.
Kanatsu K; Aihara E; Okayama M; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2004 May; 19(5):512-20. PubMed ID: 15086594
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of potential for bisphosphonates to damage gastric mucosa of rats.
Peter CP; Kindt MV; Majka JA
Dig Dis Sci; 1998 May; 43(5):1009-15. PubMed ID: 9590415
[TBL] [Abstract][Full Text] [Related]
5. Gastric damage in the rat with nitrogen-containing bisphosphonates depends on pH.
Blank MA; Gibson GW; Myers WR; Dierckman TA; Phipps RJ; Smith PN
Aliment Pharmacol Ther; 2000 Sep; 14(9):1215-23. PubMed ID: 10971239
[TBL] [Abstract][Full Text] [Related]
6. What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.
Graham DY
Dig Dis Sci; 2002 Aug; 47(8):1665-78. PubMed ID: 12184516
[TBL] [Abstract][Full Text] [Related]
7. Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa.
Thomson AB; Appleman S; Keelan M; Wallace JL
Dig Dis Sci; 2003 Feb; 48(2):308-14. PubMed ID: 12643608
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate therapy.
Licata AA
Am J Med Sci; 1997 Jan; 313(1):17-22. PubMed ID: 9001162
[TBL] [Abstract][Full Text] [Related]
9. Gastric ulcerogenic and healing impairment effects of risedronate, a nitrogen-containing bisphosphonate in rats. Comparison with alendronate and minodronate.
Amagase K; Inaba A; Senta T; Ishikawa Y; Nukui K; Murakami T; Takeuchi K
J Physiol Pharmacol; 2011 Dec; 62(6):609-18. PubMed ID: 22314563
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.
Iwata K; Li J; Follet H; Phipps RJ; Burr DB
Bone; 2006 Nov; 39(5):1053-1058. PubMed ID: 16807159
[TBL] [Abstract][Full Text] [Related]
11. 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.
Thomson AB; Marshall JK; Hunt RH; Provenza JM; Lanza FL; Royer MG; Li Z; Blank MA;
J Rheumatol; 2002 Sep; 29(9):1965-74. PubMed ID: 12233894
[TBL] [Abstract][Full Text] [Related]
12. Analgesic effect of bisphosphonates in mice.
Bonabello A; Galmozzi MR; Bruzzese T; Zara GP
Pain; 2001 Apr; 91(3):269-275. PubMed ID: 11275384
[TBL] [Abstract][Full Text] [Related]
13. [Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection].
Chen Y; Liu Y; Chen Z; Chen M; Zhu Y
Se Pu; 2012 Apr; 30(4):414-8. PubMed ID: 22799202
[TBL] [Abstract][Full Text] [Related]
14. An update on bisphosphonates.
Cohen SB
Curr Rheumatol Rep; 2004 Feb; 6(1):59-65. PubMed ID: 14713403
[TBL] [Abstract][Full Text] [Related]
15. Alendronate induces gastric injury and delays ulcer healing in rodents.
Elliott SN; McKnight W; Davies NM; MacNaughton WK; Wallace JL
Life Sci; 1998; 62(1):77-91. PubMed ID: 9444970
[TBL] [Abstract][Full Text] [Related]
16. In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat.
Jones MD; Tran CW; Li G; Maksymowych WP; Zernicke RF; Doschak MR
Arthritis Rheum; 2010 Sep; 62(9):2726-35. PubMed ID: 20533290
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance.
Fujita T; Ohue M; Fujii Y; Miyauchi A; Takagi Y
J Bone Miner Metab; 2009; 27(2):234-9. PubMed ID: 19214375
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.
Halasy-Nagy JM; Rodan GA; Reszka AA
Bone; 2001 Dec; 29(6):553-9. PubMed ID: 11728926
[TBL] [Abstract][Full Text] [Related]
19. The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium.
Twiss IM; Pas O; Ramp-Koopmanschap W; Den Hartigh J; Vermeij P
J Bone Miner Res; 1999 May; 14(5):784-91. PubMed ID: 10320527
[TBL] [Abstract][Full Text] [Related]
20. An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae.
Lanza F; Schwartz H; Sahba B; Malaty HM; Musliner T; Reyes R; Quan H; Graham DY
Am J Gastroenterol; 2000 Nov; 95(11):3112-7. PubMed ID: 11095326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
